Buyle 2010.
Methods | STUDY DESIGN: ITS Risk of Bias: LOW |
|
Participants | PROVIDERS: all physicians in hospital PARTICIPANTS: all patients receiving IV fluoroquinolones CLINICAL PROBLEM: switch from IV fluoroquinolones to oral SETTING: 1 hospital in Belgium |
|
Interventions | FORMAT, Interventions: educational meetings; dissemination of guideline; reminders ‐ circumstantial and physical (pre‐printed note placed in patient notes when the patient fulfilled criteria for IV to oral switch). NB: the circumstantial reminder was only implemented on some wards (abdominal surgery, gastro‐enterology, and plastic surgery) over 2 months, and there are no reliable data to estimate the effect of this component. Intervention Functions: education, enablement (only for the circumstantial reminder), environmental restructuring (only for the circumstantial reminder) DELIVERER: AMT COMPARISON: usual care DESIRED CHANGE: reduce inappropriate |
|
Outcomes | PRESCRIBING: Choice: % IV/(IV + oral) fluoroquinolone usage | |
Notes | FINANCIAL SUPPORT: Funding: none. Competing Interest: none declared ADDITIONAL DATA: email from authors with further information about the intervention |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Intervention independent (ITS) ? | Low risk | |
Analysed appropriately (ITS) ? | Low risk | Re‐analysed |
Shape of effect pre‐specified (ITS) ? | Low risk | Point of intervention was point of analysis. |
Unlikely to affect data collection (ITS) ? | Low risk | Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA. |
Knowledge of the allocation adequately prevented(ITS)? | Low risk | Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA. |
Incomplete outcome data addressed (ITS) ? | Low risk | Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA. |
Free of selected reporting (ITS) ? | Low risk | Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA. |
Free of other bias (ITS) ? | Low risk | 21 months' pre‐ and 24 months' postintervention |